ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,228, issued on Sept. 15, was assigned to The Regents of the University of California (Oakland, Calif.).

"Protective vaccine antigen against streptococcal infection" was invented by David J. Gonzalez (La Jolla, Calif.), Anaamika Campeau (La Jolla, Calif.) and Dominic M. McGrosso (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Group A Streptococcus (GAS) is associated with an estimated half-million deaths per year and 21 severe autoimmune sequalae. Despite the ubiquity of GAS infection, no vaccine currently exists. Provided herein is a Streptococcus S protein or an equivalent thereof used as a vaccine, along with the related composit...